2-Bromo-5,6-dihydrothieno[2,3-c]pyridin-7(4H)-one, 95.0%, 1g

Furo[2,3-b]pyridine, 95.0%, 250mg

8,9-Dihydro-5H-5,9-methanobenzo[7]annulen-7(6H)-one, 97%, 1g

4-Boc-7-Methyl-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine, 97.0%, 250mg

Fmoc-(S)-3-Amino-4-(2,4-dichloro-phenyl)-butyric acid, 97%, 250mg

Benzo[d]isoxazole, 95.0%, 1g

dimethyl sulfoxide D6, 99.9 at%D, septum vial, 10mL, septum vial

Potassium 2-methylbutan-2-olate, 98%, 500g

(3aS,4R,6aS)-2,2-Dimethyl-4-((trityloxy)methyl)-4,6a-dihydro-3aH-cyclopenta[d][1,3]dioxol-4-ol, 97%, 1g

3-(Hydroxymethyl)phenylboronic acid, 98.0%, 25g

3,3-Bis(4-hydroxy-3-methylphenyl)-3H-benzo[c][1,2]oxathiole 1,1-dioxide, 95.0%, 100g

(S)-3-Amino-1-N-Boc-pyrrolidine, 98.0%, 5g

ethyl 4-(4-cyanophenyl)-2-hydroxy-4-oxobut-2-enoate, 97%, 10g